Care and support in each case should always be based onindividually assessed needs.Only Ebixa is currentlyindicated for treating moderate to severe dementia in Alzheimer’s disease.However, the Scottish Medicines Consortium recently advised that Ebixa was notrecommended for use in NHSScotland.